From shrinking brain tumors to personalized therapies, our investigators are leading pioneering research, discovering breakthroughs in treatment, and promoting equity-driven care.
Two visionary physician leaders take pivotal new roles to amplify innovation and patient-centric advancements in Huntsman Cancer Institute’s quest for a cancer-free frontier.
Neeraj Agarwal, MD, FASCO, observed remarkable outcomes in a larger group of Talapro-2 participants with specific gene mutations, combining two cancer drugs to effectively treat advanced prostate cancer.
Jerry Simonson was diagnosed with pancreatic cancer in 2017. Now, the 76-year-old is thriving thanks to a cutting-edge clinical trial at Huntsman Cancer Institute.
Compared to other cancers, pancreatic cancer is relatively rare. But it is the third leading cause of cancer death in the United States. Only about 8.5% of patients with pancreatic...
MasterControl, a long-time Huntsman SportsFest sponsor, empowers our clinical trials and research teams to operate more efficiently and focus on advancing cancer care through its software and staff donations.
Investigators have been awarded a grant to find a better way to protect muscle mass in patients. Muscle mass plays a critical role in quality of life and cancer survival.
Researchers find way to decrease cancer deaths among Black people, begin new lung cancer clinical trial, use app to help people manage cancer, and employ games to reduce chemotherapy after-effects.
Read how scientists reduce infection risk after pancreatic surgery, discover the best cost-effective treatment for prostate cancer, learn which lung cancer patients have the most emergency department visits, and more.
Neeraj Agarwal, MD, led a global study analyzing the combination of two cancer drugs to treat metastatic prostate cancer. Results showed this reduces the risk of cancer progression by 55%.
This planned expansion in Utah County will make it easier for patients to access advanced cancer research and care, while providing more educational opportunities and engagement with the community.
The new treatment combines a modified cold virus injected directly into a tumor and an immunotherapy drug given intravenously. This breakthrough comes after many years of pre-clinical and clinical studies.
In February 2023, researchers at Huntsman Cancer Institute and the University of Utah used magnetic resonance imaging to locate tumors and high-intensity ultrasound to kill them without surgery.
Read about new melanoma treatment practices, how models provide information about a rare adrenal cancer, a potential oral medication for brain cancer, and clinical trials for cancer patients with HIV.